BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 20941619)

  • 1. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta signalling and immunity in prostate tumourigenesis.
    Diener KR; Need EF; Buchanan G; Hayball JD
    Expert Opin Ther Targets; 2010 Feb; 14(2):179-92. PubMed ID: 20055717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
    Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
    Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
    Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.
    Schmidt-Weber CB; Blaser K
    Curr Opin Immunol; 2004 Dec; 16(6):709-16. PubMed ID: 15511662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transforming growth factor-beta1 in prostate cancer.
    Wikström P; Damber J; Bergh A
    Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
    Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
    Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta signal transduction.
    Dennler S; Goumans MJ; ten Dijke P
    J Leukoc Biol; 2002 May; 71(5):731-40. PubMed ID: 11994497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
    Mantel PY; Kuipers H; Boyman O; Rhyner C; Ouaked N; Rückert B; Karagiannidis C; Lambrecht BN; Hendriks RW; Crameri R; Akdis CA; Blaser K; Schmidt-Weber CB
    PLoS Biol; 2007 Dec; 5(12):e329. PubMed ID: 18162042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.
    Schiller M; Javelaud D; Mauviel A
    J Dermatol Sci; 2004 Aug; 35(2):83-92. PubMed ID: 15265520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.